Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)-Reference-Cited by-同舟云学术

Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)

Published:2017-08-28 Issue:12 Volume:143 Page:2581-2593
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Zhang Rong-xin,Lin Jun-zhong,Lei Jian,Chen Gong,Li Li-ren,Lu Zhen-hai,Ding Pei-rong,Huang Jiong-qiang,Kong Ling-heng,Wang Fu-long,Li Cong,Jiang Wu,Ke Chuan-feng,Zhou Wen-hao,Fan Wen-hua,Liu Qing,Wan De-sen,Wu Xiao-jun,Pan Zhi-zhong

Funder

National Natural Science Foundation of China

Sun Yat-sen University 5010 research Fund

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-017-2489-0/fulltext.html

Reference32 articles.

1. Andre T et al (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109–3116. doi: 10.1200/jco.2008.20.6771

2. Cennamo V et al (2009) Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy? Clin Gastroenterol Hepatol 7:1174–1176. doi: 10.1016/j.cgh.2009.07.015